Tirzepatide conferred significantly greater weight loss than semaglutide at 72 weeks for adults with overweight or obesity, ...

Tirzepatide slashed weight by 20%, leading researchers to call this a new “golden age” for weight-loss therapies.

The first clinical trial comparing semaglutide and tirzepatide, two popular, injectable weight-loss drugs, has been published ...

As medications become increasingly popular to support weight loss, not all of them are approved by the U.S. Food and Drug ...

In the first head-to-head trial of its kind, people with obesity who took tirzepatide (sold under the brand names Mounjaro and Zepbound) lost more weight and inches from their waist than those who ...

Orlistat (sold as Alli) is one effective over-the-counter weight loss aid that is also FDA-approved.

In the first head-to-head comparison of leading incretin-based therapies, Eli Lilly’s dual GIP/GLP-1 receptor agonist ...

Weight-loss jab Mounjaro helps people shed much more weight than rival – study - Mounjaro (tirzepatide) and Wegovy ...